 REDWOOD CITY, Calif., Dec. 14, 2022 GLOBE NEWSWIRE Bolt Biotherapeutics, Inc. Nasdaq: BOLT, a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced the appointment of Laura Berner to its Board of Directors effective Dec. 14, 2022. Laura is an accomplished biopharmaceutical executive with impressive corporate leadership, operations, and business ... The post Bolt Biotherapeutics Appoints Laura Berner to Board of Directors app... 